JAL INNOVATION (SINGAPORE) PTE LTD

Company Description

JAL Innovation Singapore Pte Ltd THE EMERGING LEADER FOR BIOMEDICAL SOLUTIONS IN SINGAPORE JAL Innovation’s ultimate goal is to serve JAL INNOVATION (SINGAPORE) PTE LTD global partners with a truly integrated biomedical manufacturing facility with offering of a wide range of proprietary diabetic monitoring systems and in-vitro diagnostic test kits. Our vision is to serve our global partners and their valued customers by providing safe, reliable and cost effective solutions for diabetic monitoring and in-vitro diagnostic testing. We specialized in manufacturing advanced rapid in-vitro immunodiagnostic test systems and electrical bio sensing systems, particularly blood glucose monitoring system for home and professional uses. Our outsourced manufacturing facilities are located in Taiwan and China. They are FDA, ISO 13485 and GMP certified. Selected products are WHO, CE, FDA, 510K and CLIA Waiver approved. We have been year-marked to be one of the most promising emerging biomedical manufacturing company and amongst the largest exporter of In-Vitro Diagnostic products in Singapore. Our iCARE Global Brand of Medical products cover Health Screening; Detection of Blood Glucose Levels, Infectious Diseases, Fertility, Chronic & Critical Illnesses Alcohol and Drugs Abuses. We have a range of iCARE blood glucose monitoring systems for capillary blood, venous blood and alternate site testing to meet every demand of the market. We are seeking for Global Partners / Importers to work in close collaboration to expand our overseas markets.

Company Information

  • Contact Person:Andre HAN
  • Department:Director
  • Mobile Phone:
  • Fax:
  • Zip:188979
  • Business Type:Manufacturing
  • Year Established:2010
  • Number Of Employees:6-10
  • Trade Capacity:Export Percentage:95% %
  • Production Capacity:2
  • R&D Capacity:Less than 5 people
  • Quality Control:In House
  • No. of QC Staff:Less than 5 people
  • Contract Manufacturing:OEM Service Offered,Design Service Offered,Buyer L
  • Registered Capital:1 - 2.5 Million USD
  • Legal Representative / CEO:Andre HAN
  • Total Annual Sales Volume:2.5 - 10 Million USD
  • Main Products:Icare Blood Glucose Monitoring Systems, Dia Vida Stevia Based Sweeteners, Icare Rapid Diagnostic Test Kits,
  • Address:MIDDLE ROAD, SINGAPORE, Other, Singapore
  • Main Markets:Worldwide
  • Location:Taiwan Singapore
  • Website:Visit website
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries